Cramer’s Lightning Round: I Prefer Moderna Stock Over Novavax
It’s that time again! “Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.
Novavax: “I have to tell you even after today’s run in Moderna, I still prefer Moderna’s stock than Novavax because I think that Moderna can do a lot more with its formulation than Novavax ever can.”
Philip Morris: “It’s a very good company. I don’t recommend tobacco stocks, but it’s very well run. It makes a lot of money and it’s very good.”
Blade Air Mobility: “I think there are better ways to make money, frankly. I’m not going to recommend the stock.”
Atlassian: “I think you have to worry about its valuation because that’s why the stock is going down. I think it’s a very good company, but no company can grow as fast as it has. It’s got a $57 billion market capitalization. That’s just way too much. … I really do like the company, but I am not a buyer.”
Exact Sciences: “I think [CEO] Kevin Conroy’s running a great company. I think he’s found a lot of different ways to be able to help people and, while the stock is down, it just happens to be one of those that’s been owned by a lot of momentum guys. I’m a buyer.”
International Game Tech: “I can’t believe this IGT continues to go higher. This is computerized gaming, but they’re really the only game in town. So I get it. I guess it can go higher still. It’s been a huge winner.”
Akebia Therapeutics: “That’s a total spec. Sir, that’s just a total spec. You can do it, it’s a dice-roll spec. That’s not the kind of thing I like, but as long as you recognize it as a spec, then be my guest.”
– CNBC